{"id":754514,"date":"2025-07-30T15:10:01","date_gmt":"2025-07-30T15:10:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=754514"},"modified":"2025-07-30T15:10:01","modified_gmt":"2025-07-30T15:10:01","slug":"medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living_754514.html","title":{"rendered":"MedVi Expands Access to GLP-1 Medication &#8211; Compounded Semaglutide for Healthy Living"},"content":{"rendered":"<div style=\"font-style:italic; padding:8px 0px;\">The GLP-1 medication program by MedVi is now available nationwide starting at $179.<\/div>\n<p style=\"text-align: justify;\"><strong>NEWARK, DE &#8211;<\/strong> MedVi Wellness, a leading telehealth provider in medical weight management, has announced the launch of its nationwide GLP-1 medication program, providing compounded semaglutide in both injectable and oral forms. Starting at $179 per month with no insurance required, <a rel=\"nofollow\" href=\"https:\/\/medvi.io\">MedVi<\/a> offers an affordable, physician-guided alternative to high-cost brand-name drugs such as Wegovy&reg; and Ozempic&reg;.<\/p>\n<p style=\"text-align: justify;\">The GLP-1 medication program combines compounded semaglutide with continuous clinical oversight, 24\/7 support, and fast delivery, giving patients an accessible path to sustainable weight loss backed by medical expertise.<\/p>\n<p style=\"text-align: justify;\"><strong>GLP-1 Medications Driving a New Era in Weight Management<\/strong><\/p>\n<p style=\"text-align: justify;\">Semaglutide, a GLP-1 receptor agonist, works by reducing appetite, improving satiety, and stabilizing blood sugar levels. Clinical studies show that GLP-1 medications can help patients achieve 15&ndash;18% average weight reduction over time when combined with healthy lifestyle changes.<\/p>\n<p style=\"text-align: justify;\">&ldquo;GLP-1 medications like semaglutide have redefined medical weight loss,&rdquo; said a MedVi Wellness spokesperson. &ldquo;By offering compounded semaglutide at an affordable price point with physician oversight, we are eliminating the barriers that keep most patients from accessing this transformative therapy.&rdquo;<\/p>\n<p style=\"text-align: justify;\"><strong>Key Features of MedVi&rsquo;s GLP-1 Medication Program<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p><strong>Compounded Semaglutide Injections<\/strong> &ndash; Once-weekly dosing with pre-filled pens<\/p>\n<\/li>\n<li>\n<p><strong>Oral Semaglutide Tablets<\/strong> &ndash; A non-injectable option for daily use<\/p>\n<\/li>\n<li>\n<p><strong>Physician-Supervised Treatment<\/strong> &ndash; Personalized dosing plans from board-certified providers<\/p>\n<\/li>\n<li>\n<p><strong>Continuous Monitoring and Support<\/strong> &ndash; Unlimited check-ins and 24\/7 medical access<\/p>\n<\/li>\n<li>\n<p><strong>Fast, Nationwide Delivery<\/strong> &ndash; Temperature-controlled shipping direct to patients<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">MedVi&rsquo;s program also includes GLP-1 medication for blood sugar control, benefiting patients managing type 2 diabetes while addressing weight and metabolic health together.<\/p>\n<p style=\"text-align: justify;\"><strong>Addressing Drug Shortages and Rising Demand<\/strong><\/p>\n<p style=\"text-align: justify;\">Due to ongoing shortages of brand-name GLP-1 drugs like Wegovy&reg; and Ozempic&reg;, compounded semaglutide has become a vital alternative. MedVi sources exclusively from FDA-regulated, PCAB-accredited compounding pharmacies, ensuring pharmaceutical-grade standards and verified potency.<\/p>\n<p style=\"text-align: justify;\">&ldquo;By combining GLP-1 medication expertise with streamlined telehealth delivery, MedVi is meeting demand where traditional healthcare has fallen short,&rdquo; the spokesperson added. &ldquo;Patients no longer need to wait months or pay thousands for care.&rdquo;<\/p>\n<p style=\"text-align: justify;\"><strong>Why MedVi?<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>GLP-1 medications starting at $179\/month<\/p>\n<\/li>\n<li>\n<p>FDA-regulated compounding facilities and U.S.-licensed physicians<\/p>\n<\/li>\n<li>\n<p>Transparent, no-membership pricing<\/p>\n<\/li>\n<li>\n<p>Money-back guarantee with ongoing medical guidance<\/p>\n<\/li>\n<li>\n<p>Service availability in all 50 U.S. states<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>How It Works<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li>\n<p>Online Medical Evaluation: Complete a secure <a rel=\"nofollow\" href=\"https:\/\/medvi.org\/intakeform.php?uid=1&amp;oid=5&amp;affid=8&amp;afid=seo&amp;pub=5000\">health assessment at medvi.io<\/a>.<\/p>\n<\/li>\n<li>\n<p>Physician Review: A board-certified provider approves treatment if medically appropriate.<\/p>\n<\/li>\n<li>\n<p>Medication Delivery: GLP-1 medication ships directly to the patient&rsquo;s home, with instructions included.<\/p>\n<\/li>\n<li>\n<p>Ongoing Support: MedVi provides unlimited consultations, dose adjustments, and 24\/7 access to licensed clinicians.<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>About MedVi Wellness<\/strong><\/p>\n<p style=\"text-align: justify;\">MedVi Wellness is a U.S.-based telehealth platform dedicated to weight loss and metabolic care through GLP-1 medications. By pairing clinical expertise with convenience and affordability, MedVi empowers patients to achieve lasting health results with doctor-led guidance and transparent pricing.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/medvi.io_163300.html\" rel=\"nofollow\">MedVi Wellness<\/a><br \/><strong>Contact Person:<\/strong> Media Relations<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> (323) 690-1564<br \/><strong>Address:<\/strong>131 Continental Dr. Ste 305  <br \/><strong>City:<\/strong> Newark<br \/><strong>State:<\/strong> DE 19713<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/medvi.io\" target=\"_blank\" rel=\"nofollow\">medvi.io<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The GLP-1 medication program by MedVi is now available nationwide starting at $179. NEWARK, DE &#8211; MedVi Wellness, a leading telehealth provider in medical weight management, has announced the launch of its nationwide GLP-1 medication program, providing compounded semaglutide in &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living_754514.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,426,411,404],"tags":[],"class_list":["post-754514","post","type-post","status-publish","format-standard","hentry","category-Business","category-Financial-Market","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/754514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=754514"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/754514\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=754514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=754514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=754514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}